Monoclonal gammopathy associates with kidney failure in ANCA-associated vasculitis
Patients with AAV and renal involvement who have MG are at significantly increased risk of adverse renal events even after adjusting for factors such as eGFR and degree of chronicity (known predictors of poor renal outcome). The exact mechanism by which MG portends poor outcomes is poorly understood, and additional research is required.
Authors
- Poemlarp Mekraksakit
- Ilario Russo
- Ladan Zand (ORCID: https://orcid.org/0000-0001-5812-9809)
- Patrícia Domingues (ORCID: https://orcid.org/0000-0001-5500-4293)
- Yeshwanter Radhakrishnan (ORCID: https://orcid.org/0000-0002-1437-8894)
- António Inácio (ORCID: https://orcid.org/0000-0002-1221-4298)
- Alessia Buglioni (ORCID: https://orcid.org/0009-0008-6365-0859)
- Maria J. Vargas-Brochero (ORCID: https://orcid.org/0000-0003-0831-6221)
Institutions
- Mayo Clinic (US)
- Mayo Clinic in Arizona (US)
- Hospital de São Bernardo (PT)
- University of Bari Aldo Moro (IT)
Publication Details
- Journal
- Nephrology Dialysis Transplantation
- Published
- 2025-09-20
- DOI
- https://doi.org/10.1093/ndt/gfaf195
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00